Siren »

Cartesian Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Siren from 13F filings

Historical chart of Siren investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.2M 572k 16.12

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Cartesian Therapeutics

Siren
BlackRock
BlackRock
Jpmorgan Chase & Co
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Geode Capital Management
Logos Global Management
Northern Trust
Nuveen Asset Management
Marshall Wace
Sphera Funds Management

View all funds holding Cartesian Therapeutics